28 Feb 2020 07:00
28 February 2020
Dechra® Pharmaceuticals PLC
(Dechra, Company or the Group)
Appointment of Alison Platt as Non-Executive Director of Dechra Pharmaceuticals PLC
Dechra is pleased to announce that, with effect from 1 March 2020, Alison Platt will take up a new position as a Non-Executive Director of the Company.
Alison's appointment brings extensive experience of leadership in customer-driven organisations across the healthcare, insurance and property sectors as well as international experience she gained whilst leading a number of Bupa's businesses across Asia, Southern and Eastern Europe and the Middle East. Between 2014 and 2018 Alison was CEO of Countrywide.
Alison is currently a Non-Executive Director of Tesco PLC, and Chair of Legal & General Financial Advice (LGFA), Legal and General's newly launched financial advice business. She is a member of the steering group of the Hampton-Alexander Review and was previously Chair of Opportunity Now. Alison was awarded a CMG for services to the Foreign Office in 2011 after six years on the FCO Board and was a Non-Executive Director at Cable and Wireless Communications PLC.
Commenting on the appointment Tony Rice, Chairman, Dechra Pharmaceuticals said:
"On behalf of the Board and all stakeholders I am delighted to welcome Alison to Dechra. She brings significant capabilities and experience both in Executive and Non-Executive roles which will strengthen the Board and provide continuity during the next phase of Dechra's growth and development, as well as providing continuity over the forthcoming years with both the Senior Independent Director/Remuneration Committee Chairman and Audit Committee Chairman nine year terms expiring in 2022."
There are no other disclosures to be made in respect of Alison Platt, pursuant to Listing Rule 9.6.13R.
Enquiries to: |
Dechra Pharmaceuticals PLC |
Ian Page, Chief Executive Officer |
Office: +44 (0) 1606 814 730 |
e-mail: corporate.enquiries@dechra.com |
TooleyStreet Communications Ltd |
Fiona Tooley, Director Mobile: +44 (0) 7785 703 523 e-mail: fiona@tooleystreet.com |
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and relates products business. Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.
For more information please visit: www.dechra.com
Stock Code: Full Listing (Pharmaceuticals): DPH
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.